Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation

Bone Marrow Transplant. 1989 Sep;4(5):553-8.

Abstract

We previously described an exponential correlation of the CFU-GM content of 4-hydroperoxycyclophosphamide-treated autologous bone marrow grafts and the rate of hematologic recovery of the recipients after transplantation. Those grafts were assayed before cryopreservation. We now describe a similar analysis based upon cultures of the thawed bone marrow. In a proportional hazards model, the CFU-GM content of the grafts sampled after thawing predicted time to achieving a peripheral blood count of 1 X 10(9)/l leukocytes, 0.5 X 10(9)/l granulocytes, 2% reticulocytes, and last platelet transfusion (p less than 0.001). Using linear regression analysis, the logarithm of the CFU-GM content/kg of recipient weight also was correlated with the time to achieving 1 X 10(9)/l leukocytes (r = -0.62), and 0.5 X 10(9)/l granulocytes (r = -0.66). The hazard ratios (Cox model) and regression coefficients (linear regression model) for the equations calculated from the post-thaw cultures were usually smaller than the corresponding coefficients based upon the pre-freeze cultures, suggesting that pre-freeze cultures may be more accurate predictors of aplasia duration. However, patients with poor post-freeze survival of CFU-GM were more likely to experience delayed engraftment. Therefore, the correlation of post-thaw cultures with engraftment may permit the analysis of cryopreservation techniques.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Blood Cell Count
  • Bone Marrow / drug effects
  • Bone Marrow / pathology
  • Bone Marrow Transplantation* / pathology
  • Child
  • Child, Preschool
  • Colony-Forming Units Assay
  • Cryopreservation
  • Cyclophosphamide / analogs & derivatives*
  • Cyclophosphamide / therapeutic use
  • Female
  • Hematopoiesis
  • Humans
  • Male
  • Middle Aged
  • Time Factors
  • Transplantation, Autologous

Substances

  • Cyclophosphamide
  • perfosfamide